However, there have also been reports of CXCL9, CXCL10, and CXCL11 that promote tumor proliferation in colon cancer, esophageal adenocarcinoma, and head and neck cancer by promoting inflammation or other mechanisms [44–47]. Here, CXCL10 is linked to esophageal adenocarcinoma.